Infectiologic differential diagnosis of chronic Lyme disease and so ...

More documents

Recommendations

Info

[155] Cover TL, Aber RC. Yersinia enterocolitica. N Enl J Med 1989; 321(1): 16-24. [156] Black RE, Slome S. Yersinia enterocolitica. Inefct Dis Clin North Am 1988; 2(3): 625-41. [157] Reed RP, Robins-Browne RM, Williams ML. Yersinia enterocolitica peritonitis. Clin Infect Dis 1997; 25(6): 1468-9. [158] Blinkhorn RJ Jr, Marino JA. Lateral pharyngeal abscess due to Yersinia enterocolitica. Am J Med 1988; 85(6): 851-2. [159] Krogstad P, Mendelman PM, Miller VL et al. Clinical and microbiologic characteristics of cutaneuous infection with Yersinia enterocolitica. J Infect Dis 1992; 165(4): 740-3. [160] Crowe M, Ashford K, Ispahani P. Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. J Infect Microbiol 1996; 45(4): 302-9. [161] Kellogg CM, Tarakji EA, Smith M, Brown PD. Bacteremia and suppurative lymphadenitis due to Yersinia enterocolitica in a neutropenic patient who prepared chitterlings. Clin Infect Dis 1995; 21(1): 236-7. [162] van der Heijden IM, Res PC, Wilbrink B et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis 1997; 25(4): 831-7. [163] Granfors K, Jalkanen S, von Essen R et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320(4): 216-21. [164] Granfors K, Merilahti-Palo R, Luukkainen R et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998; 41(5): 855- 62. 76
[165] Leirisalo-Repo M, Suoranta H. Ten-year follow-up study of patient with Yersinia arthritis. Arthritis Rheum 1988; 31(4): 533-7. [166] Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10(2): 257-76. [167] Mäki-Ikola O, Heesemann J, Toivanen A, Granfors K. High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 1997; 16(6): 227-9. [168] Ostroff SM. Clinical features and diagnosis of Yersinia enterocolitica and Yersinia pseudotuberculosis infection. UpToDate, 2009. [169] Lindblom A , Isa A, Norbeck O et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005; 41(8): 1201-3. [170] Lowry SM, Brent LH, Menaldino S, Kerr JR. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists. Clin Infect Dis 2005; 41(4):e42-4. [171] Nikkari S, Roivainen A, Hannonen P et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995; 54(7): 597-600. [172] Kühl U, Pauschinger M, Seeberg B et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112(13): 1965-70. [173] Tschöpe C, Bock CT, Kasner M et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005; 111(7): 879-86. [174] Donoso Mantke O, Nitsche A, Meyer R, Klingel K, Niedrig M. Analysing myocardial tissue from explanted hearts of heart transplant recipients and 77
Page 1 and 2:
Infectiologic differential diagnosi
Page 3 and 4:
3 Anamnistically, one has to consid
Page 5 and 6:
Table 2 LD coinfections (not tick-b
Page 7 and 8:
Table 5 Bartonellosis’ infection
Page 9 and 10:
Table 6 Main disease manifestations
Page 11 and 12:
11 Fig. 1. Erythrocytes infected wi
Page 13 and 14:
13 Bartonellae are localized in ery
Page 15 and 16:
ESR und CRP elevated Hypercalcemia
Page 18 and 19:
Table 9 Antibiotic treatment of bar
Page 20 and 21:
antibiosis is that the antibiotic i
Page 22 and 23:
The laboratory diagnostics for Chla
Page 24 and 25:
The arthritis occurs in 1% of the u
Page 26 and 27: In the differential diagnosis of Ly
Page 28 and 29: Late phase: - Reactive arthritis -
Page 30 and 31: the depiction of chronic yersiniosi
Page 32 and 33: In Yersinia-PCR-positive patients,
Page 34 and 35: - Incubation period 3 weeks - Atypi
Page 36 and 37: system, of the skin and other organ
Page 38 and 39: - Ehrlichia chaffeensis [1] - Anapl
Page 40 and 41: Since seroprevalence merely express
Page 42 and 43: B. microti is the predominant patho
Page 44 and 45: epresent a major health hazard and
Page 46 and 47: The decisive diagnostic information
Page 48 and 49: Probable: IFA IgG 1:1024 and one of
Page 50 and 51: The main manifestation of the Campy
Page 52 and 53: The term “reactive arthritis” i
Page 54 and 55: In the diagnosis of a “reactive a
Page 56 and 57: Table 27 Disease manifestations of
Page 58 and 59: addition, other pathogens discussed
Page 60 and 61: [8] Schouls LM, Van De Pol I, Rijpk
Page 62 and 63: [25] Hermanowska-Szpakowicz T, Skot
Page 64 and 65: [43] Bakken JS, Krueth JK, Lund T,
Page 66 and 67: [60] Fox LM, Wingerter S, Ahmed A e
Page 68 and 69: [80] Marra CM. Neurologic complicat
Page 70 and 71: [100] Pulliainen AT, Dehio C. Barto
Page 72 and 73: [118] Bass JW, Freitas BC, Freitas
Page 74 and 75: [137] Gaydos CA, Roblin PM, Hammers
Page 78 and 79: multi-organ donors for the presence
Page 80 and 81: [190] Straubinger RK, Straubinger A
Page 82 and 83: [208] Bitnun A, Ford-Jones E, Blase
Page 84 and 85: patients with reactive and undiffer
Page 86 and 87: [242] Appelbaum PC, Gillespie SH, B
Page 88 and 89: pneumoniae infection associated wit
Page 90 and 91: [276] Thomas NH, Collins JE, Robb S
Page 92 and 93: [294] File TM Jr, Segreti J, Dunbar
Page 94 and 95: [310] Sorvillo FJ, Lieb LE, Waterma
Page 96 and 97: henselae Isolates Collected from Ca
Page 98 and 99: [345] Raoult D, Levy PY, Harlé JR,
show all

Infectiologic differential diagnosis of chronic Lyme disease and so ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?